Now is the time to review your UK R&D processes and prepare for the future
HMRC continues to provide generous investment incentives to UK companies. Most significant amongst these is the UK R&D tax relief. Recent statistics showed that 60,000 companies received £7.5 billion of this long-standing R&D benefit. In a fiscally challenging environment, HMRC wants to ensure the taxpayers are getting value for money and thus placing claims under greater scrutiny and looking to better target the incentive, as demonstrated through recent HMRC announcements.
In parallel, tax departments are pressured to ‘do more with less’ to secure the incentives they are entitled to through more efficient and timely claim methodologies.
Are you eligible?
If you can answer yes to any of the queries below, then you are likely to be undertaking R&D, as defined for tax purposes:
- Do you employ in-house engineers/software developers?
- Do you develop new, or significantly improve existing, products, processes and services?
- Are you undertaking transformational programmes to improve cost parity or develop competitive advantage?
You can learn more about industry-specific case studies and the benefits our trusted advisors have delivered for clients by downloading our brochure.
A&M Case Studies >
Companies faced with these conflicting pressures need a trusted advisor to guide their business through the increased HMRC scrutiny to efficiently secure the full R&D benefits that they are entitled to. This is where A&M comes in.
Connect With Us
> More about why A&M is the right fit for your business.
Download the UK R&D Tax Relief brochure
Code of Practice 9 – What Is It and Is It Right for You?
December 12, 2025
At A&M, we regularly work alongside our clients’ existing advisors to ensure that they benefit from our extensive experience in managing Code of Practice 9 enquiries.
A&M Benefits Reference Guide
December 11, 2025
Many of the limits that pertain to qualified retirement plans and benefit plans are set by the Internal Revenue Service (IRS) and are subject to cost-of-living adjustments. In 2026, employees will be able to increase their retirement savings and contributions to health savings accounts as a result of the increased limits. The IRS limits for 2026 are summarized in the table below along with certain important compliance deadlines.
Pharma in Focus: A Prescription for Thai Tax & Tariff Health
December 8, 2025
Alvarez & Marsal recently hosted an engaging and practical session tailored for tax, finance, and trade professionals in the pharmaceutical industry. This first edition of our Thailand Tax Talk: Industry Series explored how tax leaders in the pharma sector can respond to increasing regulatory pressure, operational complexity, and cross-border trade disruption.
Supreme Court Upholds Delhi High Court Ruling: Indian Subsidiary Does Not Automatically Constitute PE, and No Further Profit Attribution Is Warranted Once the Subsidiary Arm’s Length Remuneration Is Paid
December 5, 2025
The Supreme Court’s affirmation of the Delhi High Court ruling in the Progress Rail case provides important clarity on Permanent Establishment standards in India.
The decision reinforces key principles on control, core functions, agency thresholds, and profit attribution.
It further underscores that arm’s-length remuneration to Indian subsidiaries precludes additional attribution.
A significant development for multinational enterprises evaluating their India-linked operating models.
